Beneficient BENF under CEO Bradley Heppner
April 29, 2024 by
CuriosityStream Inc CURI under CEO Clinton Stinchcomb
April 1, 2024 by
Cullman Bancorp, Inc. CULL under CEO John Riley
April 1, 2024 by
TFF Pharmaceuticals Inc TFFP under CEO Harlan Weisman
March 27, 2024 by
Eiger BioPharmaceuticals Inc EIGR under CEO David Apelian
March 21, 2024 by
Janux Therapeutics Inc JANX under CEO David Campbell
March 18, 2024 by
Minerva Neurosciences Inc NERV under CEO Remy Luthringer
March 18, 2024 by
Pyxis Oncology Inc PYXS under CEO Lara Sullivan
March 18, 2024 by
Supercom Ltd SPCB under CEO Ordan Trabelsi
March 18, 2024 by
